Abound Wealth Management’s Abiomed Inc ABMD Stock Holding History

Abound Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	-$246	–	796
2022 Q3	$246	Buy	+1	New	+$270	﹤0.01%	703

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Abound Wealth Management's ABMD Position: Q4 2022 in Review

Abound Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1 share — an estimated $246 sold.

Abound Wealth Management first reported a position in ABMD in Q3 2022 and held it in 1 quarter. The position peaked at $246 in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Abound Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Abound Wealth Management sold 1 Abiomed Inc share in Q4 2022, an estimated $246.
Abound Wealth Management first reported a position in Abiomed Inc in Q3 2022 and held it in 1 quarter.
Abound Wealth Management's Abiomed Inc position peaked at $246 in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Abound Wealth Management's 13F filing for Q4 2022, filed 7 Aug 2024.